• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Dental Anesthesia Market

    ID: MRFR/Pharma/0271-CR
    110 Pages
    Rahul Gotadki
    November 2022

    Dental Anesthesia Market Research Report Information by Product Type (Lidocaine, Mepivacaine, Prilocaine, Bupivacaine 0.5% with epinephrine1:200,000, Articaine and Others), by Mode of Administration (Maxillary, Mandibular and Others) by Technique (Local Infiltration, Field Block and Nerve Block), by Duration of Action (Short, Medium and Long), by End User (Hospital Clinics, Clinics and Other), by Distribution Channel (Pharmacies And Drug Stores, E-Commerce and Other) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—F...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Dental Anesthesia Market Research Report—Global Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    Dental Anesthesia Market Summary

    As per Market Research Future Analysis, the dental anesthesia market is projected to reach USD 3.08 Billion by 2032, growing at a CAGR of 5.8% from 2024 to 2032. The market is driven by the increasing geriatric population, rising prevalence of dental diseases, and the introduction of innovative products. However, challenges such as a shortage of skilled anesthesiologists and strict regulatory guidelines may hinder growth. The COVID-19 pandemic has negatively impacted the market, leading to a decline in dental procedures and a shortage of anesthetic drugs globally. Despite these challenges, the demand for dental anesthesia is expected to rise due to the growing trend towards dental health check-ups and advancements in dental technology.

    Key Market Trends & Highlights

    Key trends influencing the dental anesthesia market include:

    • High prevalence of dental diseases affecting nearly 3.5 billion people globally (WHO, 2020).
    • Increasing geriatric population contributing to higher demand for dental procedures.
    • Shortage of anesthesiologists projected to reach 124,000 by 2034 (AAMC).
    • Introduction of new dental anesthesia products enhancing patient care and comfort.

    Market Size & Forecast

    2024-2032 Market Size USD 3.08 Billion
    CAGR 5.8%

    Major Players

    Dentsply Sirona (US), Septodont, Inc (France), AstraZeneca (UK), Primex Pharmaceuticals (Europe), 3M (US), Centrix, Inc (US), Cetylite, Inc (US), Crosstex International, Inc. (US), DMG America (US), Henry Schein, Inc. (US), Patterson Companies, Inc. (US), Pierrel SPA (Italy)

    Dental Anesthesia Market Trends

    Drivers

      • High prevalence of dental diseases

    Periodontal disease, also known as gum disease, is mainly the result of infections and inflammation of the gums and bones surrounding and supporting the teeth. According to the WHO, in 2020, severe periodontal (gum) disease affected almost 10% of the global population. The increasing prevalence of such dental issues is accelerating the demand for oral screening and surgeries around the globe, further creating a demand for dental anesthesia. This is driving the global dental anesthesia market.

      • Increasing trend towards dental health check-up
      • Growing geriatric population worldwide

    Restraints

      • Dearth of skilled anaesthesiologists

    Anesthesia is a vital medical specialty provided by highly skilled professionals such as certified registered nurse anesthetists (CRNAs) and anesthesiologists (ANs). Anesthesiologists evaluate, monitor, and supervise patient care before, during, and after surgery while delivering anesthesia. There is a shortage of skilled anesthesiologists across the globe. According to the Association of American Medical Colleges (AAMC), around 38,000 to 124,000 physicians are expected to be needed by 2034, with roughly 12,500 of them being anesthesiologists.

    Moreover, it is estimated that there are billions of people around the globe who lack access to safe surgery for various reasons, including the lack of trained anesthesia providers. People living in developing and developing countries have the fewest specialists who unduly affect their health care.  The shortage of anesthesiologists affects dental screening and treatment throughout the globe. Hence, the shortage of skilled anesthesiologists is hampering the global dental anesthesia market.

    Opportunity

      • Introduction of new dental anesthesia products

    The introduction of new dental anesthesia products into the market is creating opportunities for players involved in the dental anesthesia market. The new technologically advanced dental products are used for superior patient care as well as to add comfort to professional practice. These advancements in products are making dental procedures faster and easier. For instance, in May 2017, Cetylite Inc. designed a new flavor of one of its flagship products, Cetacaine Topical Anesthetic Gel. Cetacaine aimed to feature a cool mint-flavored gel for oral anesthetic applications. It is primarily used to control pain and ease discomfort at the application site.

    Supply Chain Analysis

    The global market's supply chain analysis comprises five major components that start with the R&D and designing, manufacturing, distribution, marketing & sales, and post-sales monitoring.

    In R&D process, new drug designs are introduced to enhance product quality and mix them with advanced compositions. As there are a variety of products available in the market, many companies are investing in R&D for high-quality drug offerings. R&D is a brainstorming process and requires sound knowledge and skills. After the R&D is over, the developers start manufacturing dental anaesthesia based on the inputs. The stage is characterized by primarily four steps — conceptualization, product designing, product development, and testing to ensure quality standards.

    The cost of this process can be reduced by finding substitutes for the raw material or by modifying the conventional manufacturing process.

    Manufacturing is a fast process, which is followed by the testing of the product. After this, distribution, marketing & sales is the most crucial part of the supply chain. Distribution includes intermediaries, direct selling, online channels, and others. To increase awareness in the market, the leading players are conducting seminars and sessions, which give dental practitioners an idea about the availability of the new refined products. For this, a company's marketing and sales strategies play a crucial role in understanding the characteristics of the industry in which it is competing.

    The companies operating in the market are more inclined toward creating a subsidiary in a new region for better product reach and availability.

    And lastly, post-sales monitoring plays a very important role in this market. As the global market is competitive and patient-centric, post-sales monitoring is a must to understand product performance.

    The increasing emphasis on patient comfort and safety in dental procedures appears to drive the evolution of innovative anesthesia techniques and products in the dental sector.

    U.S. Food and Drug Administration (FDA)

    Dental Anesthesia Market Drivers

    Market Growth Projections

    The Global Dental Anesthesia Market Industry is projected to experience substantial growth over the next decade. With a market value of 1.48 USD Billion in 2024, it is anticipated to reach 3.65 USD Billion by 2035, reflecting a CAGR of 8.53% from 2025 to 2035. This growth is driven by various factors, including technological advancements, increasing dental procedures, and a growing geriatric population. The market's expansion indicates a robust demand for innovative anesthesia solutions that cater to diverse patient needs and preferences.

    Increasing Geriatric Population

    The Global Dental Anesthesia Market Industry is poised for growth due to the rising geriatric population, which often requires dental care and anesthesia for various procedures. As individuals age, they tend to experience more dental issues, necessitating treatments that involve anesthesia. This demographic shift is expected to drive market expansion, with the geriatric population projected to reach 1.5 billion by 2030. Consequently, the demand for safe and effective dental anesthesia solutions tailored to older patients will likely increase, further solidifying the industry's growth trajectory.

    Growing Awareness of Oral Health

    There is a growing awareness of oral health among the global population, which is positively influencing the Global Dental Anesthesia Market Industry. Educational campaigns and initiatives by health organizations are emphasizing the importance of regular dental check-ups and treatments. This heightened awareness is leading to an increase in dental visits, thereby driving the demand for anesthesia services. As the market evolves, it is expected that the focus on preventive care will continue to grow, resulting in a more significant need for effective dental anesthesia solutions to ensure patient comfort during procedures.

    Rising Demand for Dental Procedures

    The Global Dental Anesthesia Market Industry is experiencing a notable increase in demand for dental procedures, driven by a growing awareness of oral health and aesthetics. As more individuals seek cosmetic dental treatments, the need for effective anesthesia options rises. In 2024, the market is projected to reach 1.48 USD Billion, reflecting the increasing number of dental surgeries performed globally. This trend is likely to continue, as advancements in dental technology and techniques enhance patient experiences, thereby further propelling the demand for dental anesthesia solutions.

    Expansion of Dental Clinics and Practices

    The expansion of dental clinics and practices worldwide is a crucial driver for the Global Dental Anesthesia Market Industry. As more dental professionals establish practices, particularly in emerging economies, the demand for dental anesthesia is expected to rise. This expansion is facilitated by increased investments in healthcare infrastructure and the establishment of dental schools, which produce a steady stream of qualified practitioners. By 2035, the market is projected to reach 3.65 USD Billion, indicating a robust growth trajectory fueled by the proliferation of dental services and the corresponding need for anesthesia.

    Technological Advancements in Anesthesia Delivery

    Technological innovations in anesthesia delivery systems are significantly impacting the Global Dental Anesthesia Market Industry. The introduction of computer-controlled local anesthetic delivery systems and advanced monitoring devices enhances the precision and safety of anesthesia administration. These advancements not only improve patient comfort but also reduce the risk of complications during dental procedures. As a result, dental practitioners are increasingly adopting these technologies, contributing to the market's growth. The anticipated CAGR of 8.53% from 2025 to 2035 indicates a robust future for these innovations within the industry.

    Market Segment Insights

    Dental Anesthesia Product Type Insights

    Global Dental Anesthesia Market Share (%), by Product Type Source: Market Research Future Analysis

    Lidocaine

    Lidocaine is the most used anesthetic in dental surgeries and procedures, which is further bifurcated into lidocaine 2% with epinephrine 1:100,000, lidocaine 2% with epinephrine 1:50,000, and lidocaineonly. Leading market players are developing cost-effective and painless administration of anesthetics, boosting the dental anesthetics market. The global dental anesthetics market is expected to introduce high-quality and efficient products in the upcoming years owing to great number of research activities funneled in the same. Further, advanced dental anesthetics have enabled healthcare professionals to perform complicated surgeries without compromising patients’ preference for minimal pain. These factors promote the growth of the market segment.

    Mepivacaine

    Mepivacaine is an anesthetic that blocks the nerve impulses that send pain signals to the brain. Further, the market segment is bifurcated into mepivacaine 2% with levonordefrin 1:20,000 and mepivacaine 3%. The market product gains major consumption owing to the usage in local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. It is also used as an anesthetic for the epidural or spinal block.

    Dental Anesthesia Mode of Administration Insights

    Maxillary

    The maxillary anesthesia is used to anesthetize the posterior superior alveolar nerve before it enters the posterior surface of the maxilla while it is in the infra-temporal fossa infra. It also helps to anesthetize the pulp, investing structures, and buccal mucoperiosteum of the maxillary molars except for the mesiobuccal root of the first molar. It is bifurcated into supraperiosteal injection, intraseptal injection, periodontal ligament injection, and periapical injection.

    Mandibular

    Mandibular block anesthesia plays an important role in providing profound anesthesia to the mandible. It is divided into IAN, akinosi, gow-gates, and tissue or skin. Several several mandibular blocks have been developed to provide profound anesthesia without the technical challenges of completing successful mandibular blocks.

    Others

    Dental Anesthesia Technique Insights

    Local infiltration

    Local infiltration (also known as supraperiosteal injection) is one of the most used techniques for achieving anesthesia of the maxillary dentition. This technique is indicated when an individual tooth is to be treated.

    Field Block

    Field block indicates when an individual tooth or a specific isolated area requires anesthesia. It is performed within the direct vicinity of the site of infiltration. It also helps to anesthetize the terminal nerve branches in the treatment area. It is used for the longer duration of anesthesia and flexibility to accommodate the clinical situation.

    Nerve Block

    Dental Anesthesia Duration of Action Insights

    Short

    Local anesthetics vary in their duration of action due to primarily differences in their affinity for protein. Like most drugs, local anesthetics reversibly bind to plasma proteins while circulating in the bloodstream. For example, lidocaine is the most used local anesthetic in the US.

    Medium

    The medium duration of anesthesia is influenced by the time a local anesthetic remains near neural fibers. Topical or local infiltration administration of Articaine proved to be sufficient for dental procedures requiring anesthesia with a short to intermediate duration of action and fast onset. Articaine is the second most popular local dental anesthetic drug in the US, currently holding a major share of the US region

    Long

    Dental Anesthesia End user Insights

    Hospital clinics

    The dramatic rise in tooth restoration is attributed to the increasing number of tooth infections and disorders. This is because hospital clinics provide patients with dental restorations in a single visit. The health care system for the geriatric population is considered a major concern within the health care sector.

    Clinics

    Dental anesthetics continue to witness lucrative opportunities worldwide on the backdrop of the increasing number of surgery centers and clinics worldwide. Moreover, the growth in the healthcare industry is likely to influence the dental anesthetics market squarely. Dental anesthetics are being adopted by dental clinics such as Mayo Clinic Dentistry and UCSF Dental Center due to the growing demand for painless surgeries.

    Other

    Dental Anesthesia Distribution Channel Insights

    Pharmacies & Drug Store

    Many drug stores across the globe maintain an internal pharmacy to support the patients and their family members. The increasing number of individuals, chain pharmacies, and drug stores also supports dental anesthesia sales. Pharmacies and drug stores are expected to hold a substantial market share due to the availability of medical experts such as dermatologists and neurologists, cancer specialists, and hospital accessibility.

    E-commerce

    An e-commerce or online pharmacy is a store that sells pharmaceutical preparations such as non-prescription and prescription drugs over the internet and through the mail. As the digital world expands and online technologies and consumer-friendly online experiences emerge, the business is shifting towards to direct-to-patient model. The convenience and familiarity of online purchasing have prompted many patients to seek virtual care medications and wellness options.

    Other

    Get more detailed insights about Dental Anesthesia Market Research Report—Global Forecast till 2032

    Regional Insights

    Key Companies in the Dental Anesthesia Market market include

    Industry Developments

    In July 2021, Septodont acquired Sanofi’s four dental care brands Ultracain, Rodogyl, Birodogyl and Dontisolon. This acquisition was done to strengthen the parent company’s product offerings.

    In July 2019, OGNA expanded its market in Europe. This expansion aims to provide the product offering of the company in Europe region.

    In January 2018, Cetylite announced the launch of Cetacaine topical anaesthetic spray in a single-patient package. The single-patient spray eliminates the threat of cross-contamination caused by multiple patient usages. Moreover, Bar Code Medication Administration (BCMA) inclusion further enhances accuracy, averts medication errors, and improves efficiency.

    Future Outlook

    Dental Anesthesia Market Future Outlook

    The Global Dental Anesthesia Market is projected to grow at 8.53% CAGR from 2024 to 2035, driven by technological advancements, increasing dental procedures, and rising patient awareness.

    New opportunities lie in:

    • Invest in innovative local anesthesia delivery systems to enhance patient comfort.
    • Develop digital platforms for anesthesia management to streamline dental practices.
    • Explore partnerships with dental clinics for bundled service offerings to increase market reach.

    By 2035, the market is expected to achieve substantial growth, reflecting evolving dental care demands.

    Market Segmentation

    Dental Anesthesia End User Outlook

    • Hospital Clinics
    • Clinics
    • Other

    Dental Anesthesia Technique Outlook

    • Local Infiltration
    • Field Block
    • Nerve Block

    Dental Anesthesia Regional Outlook 

    North America
    • US
    • Canada
    • South America

    Dental Anesthesia Product Type Outlook

    • Lidocaine
    • Mepivacaine
    • Prilocaine
    • Bupivacaine 0.5% with epinephrine1:200,000
    • Articaine
    • Others

    Dental Anesthesia Duration of Action Outlook

    • Short
    • Medium
    • Long

    Dental Anesthesia Distribution Channel Outlook

    • Pharmacies And Drug Stores
    • E-Commerce
    • Other

    Dental Anesthesia Mode of Administration Outlook

    • Maxillary
    • Mandibular
    • Others

    Report Scope

    Attribute/Metric Details
      Market Size   2032: USD 3.08 Billion
      CAGR   5.8%
      Base Year   2023
      Forecast Period   2024-2032
      Historical Data   2020
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors and Trends
      Segments Covered   Type, Deployment, End User, and Region
      Geographies Covered   Americas, Europe, Asia-Pacific, Middle East & Africa
      Key Vendors   Dentsply Sirona (US), Septodont, Inc. (France), AstraZeneca (UK), Primex Pharmaceuticals (Europe), 3m (US), Centrix, Inc (US), Cetylite, Inc (US), Crosstex International, Inc. (US), Dmg America (US), Henry Schein, Inc. (US), Patterson Companies, Inc. (US), Pierrel SPA (Italy)
      Key Market Opportunities   • Introduction of new dental products
      Key Market Drivers   • High prevalence of dental diseases • Increasing trend towards dental health check-up • Growing geriatric population worldwide

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the CAGR of the Dental Anesthesia Market?

    Dental Anesthesia Market is expected to exhibit a strong 5.8% CAGR over the forecast period from 2024-2032.

    What is the major driver for the Dental Anesthesia Market?

    Growing awareness about dental health and the increasing volume of dental procedures is the major driver for the Dental Anesthesia Market.

    What is the key restraint on the Dental Anesthesia Market?

    The unavailability of skilled anesthetists is a key restraint on the Global Dental Anesthesia Market.

    Which is the leading regional Dental Anesthesia Market?

    The Americas dominate the Global Dental Anesthesia Market.

    What are the leading Dental Anesthesia Market players?

    Leading players in the Global Dental Anesthesia Market include GSK, Dentsply Sirona, and Septodont, among others.

    1. 'TABLE OF CONTENTS
    2. EXECUTIVE SUMMARY
      1. OVERVIEW
    3. MARKET INTRODUCTION
      1. DEFINITION
      2. SCOPE OF THE STUDY
      3. RESEARCH OBJECTIVE
      4. LIST OF ASSUMPTIONS
    4. RESEARCH METHODOLOGY
      1. OVERVIEW
      2. DATA MINING
      3. SECONDARY
    5. RESEARCH
      1. PRIMARY RESEARCH
        1. PRIMARY INTERVIEWS AND INFORMATION
    6. GATHERING PROCESS
      1. BREAKDOWN OF PRIMARY RESPONDENTS
      2. FORECASTING
    7. TECHNIQUES
      1. RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
        1. BOTTOM-UP
    8. APPROACH
      1. TOP-DOWN APPROACH
      2. DATA TRIANGULATION
      3. VALIDATION
    9. MARKET DYNAMICS
      1. OVERVIEW
      2. DRIVERS
        1. HIGH PREVALENCE
    10. OF DENTAL DISEASES
      1. INCREASING TREND TOWARDS DENTAL HEALTH CHECK-UP
        1. GROWING GERIATRIC POPULATION WORLDWIDE
      2. RESTRAINTS
        1. DEARTH
    11. OF SKILLED ANESTHESIOLOGISTS
      1. OPPORTUNITIES
        1. INTRODUCTION OF NEW
    12. DENTAL PRODUCTS
    13. MARKET FACTOR ANALYSIS
      1. SUPPLY CHAIN ANALYSIS
        1. R&D AND DESIGNING
        2. MANUFACTURING
        3. DISTRIBUTION,
    14. MARKETING & SALES
      1. POST-SALES MONITORING
      2. PORTER''S FIVE FORCES
    15. MODEL
      1. THREAT OF NEW ENTRANTS
        1. BARGAINING POWER OF SUPPLIERS
        2. THREAT OF SUBSTITUTES
        3. BARGAINING POWER OF BUYERS
        4. RIVALRY
      2. IMPACT ANALYSIS OF COVID-19 ON DENTAL ANESTHESIA MARKET
        1. OVERVIEW
        2. IMPACT ON GROWTH OF THE MARKET
        3. IMPACT ON TRADE OF MAJOR MANUFACTURES
        4. IMPACT IN MAJOR REGIONS
        5. IMPACT ON THE MANUFACTURING PROCESS
    16. GLOBAL DENTAL ANESTHESIA MARKET, BY PRODUCT TYPE
      1. OVERVIEW
    17. LIDOCAINE
      1. MEPIVACAINE
      2. PRILOCAINE
      3. BUPIVACAINE 0.5% WITH
    18. EPINEPHRINE1:200,000
      1. ARTICAINE
      2. OTHERS
    19. GLOBAL DENTAL ANESTHESIA
    20. MARKET, BY MODE OF ADMINISTRATION
      1. OVERVIEW
      2. MAXILLARY
    21. MANDIBULAR
      1. OTHERS
    22. GLOBAL DENTAL ANESTHESIA MARKET, BY TECHNIQUE
      1. OVERVIEW
      2. LOCAL INFILTRATION
      3. FIELD BLOCK
      4. NERVE BLOCK
    23. GLOBAL DENTAL ANESTHESIA MARKET, BY DURATION OF ACTION
      1. OVERVIEW
      2. SHORT
      3. MEDIUM
      4. LONG
    24. GLOBAL DENTAL ANESTHESIA MARKET,
    25. BY END USER
      1. OVERVIEW
      2. HOSPITAL CLINICS
      3. CLINICS
    26. OTHER
    27. GLOBAL DENTAL ANESTHESIA MARKET, BY DISTRIBUTION CHANNEL
    28. OVERVIEW
      1. PHARMACIES AND DRUG STORES
      2. E-COMMERCE
      3. OTHER
    29. GLOBAL DENTAL ANESTHESIA MARKET, BY REGION
      1. OVERVIEW
      2. AMERICAS
        1. NORTH AMERICA
        2. SOUTH AMERICA
      3. EUROPE
        1. WESTERN EUROPE
    30. EUROPE
      1. EASTERN EUROPE
      2. ASIA-PACIFIC
        1. CHINA
        2. JAPAN
        3. INDIA
        4. AUSTRALIA
        5. SOUTH KOREA
        6. REST OF ASIA-PACIFIC
      3. MIDDLE EAST & AFRICA
        1. MIDDLE
    31. EAST
      1. AFRICA
    32. COMPETITIVE LANDSCAPE
      1. OVERVIEW
    33. COMPETITIVE BENCHMARKING
      1. MAJOR GROWTH STRATEGY IN DENTAL ANESTHESIA MARKET
      2. THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN DENTAL ANESTHESIA
    34. MARKET
      1. KEY DEVELOPMENT ANALYSIS
      2. KEY DEVELOPMENTS & GROWTH
    35. STRATEGIES
      1. PRODUCT APPROVALS AND PRODUCT LAUNCHES
        1. EXPANSIONS/AGREEMENT
        2. MERGERS & ACQUISITIONS
      2. MAJOR PLAYERS SALES ANALYSIS
    36. MAJOR PLAYERS R&D ANALYSIS
    37. COMPANY PROFILES
      1. DENTSPLY SIRONA
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      2. SEPTODONT, INC.
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. ASTRAZENECA
        1. COMPANY OVERVIEW
    38. FINANCIAL OVERVIEW
      1. PRODUCTS OFFERED
        1. KEY DEVELOPMENTS
        2. SWOT ANALYSIS
        3. KEY STRATEGIES
      2. PRIMEX PHARMACEUTICALS
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      3. 3M
        1. COMPANY
    39. OVERVIEW
      1. FINANCIAL OVERVIEW
        1. PRODUCTS OFFERED
    40. KEY DEVELOPMENTS
      1. SWOT ANALYSIS
        1. KEY STRATEGIES
    41. CENTRIX, INC.
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
    42. PRODUCTS OFFERED
      1. KEY DEVELOPMENTS
        1. KEY STRATEGIES
    43. CETYLITE, INC.
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
    44. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. KEY STRATEGIES
      2. CROSSTEX INTERNATIONAL, INC.
        1. COMPANY OVERVIEW
        2. FINANCIAL
    45. OVERVIEW
      1. PRODUCTS OFFERED
        1. KEY DEVELOPMENTS
        2. SWOT
    46. ANALYSIS
      1. KEY STRATEGIES
      2. DMG AMERICA
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      3. HENRY SCHEIN, INC.
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      4. PATTERSON COMPANIES,
    47. INC. (PATTERSON DENTAL)
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
        2. PRODUCTS OFFERED
        3. KEY DEVELOPMENTS
        4. KEY STRATEGIES
      2. PIERREL SPA
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
    48. APPENDIX
      1. REFERENCES
      2. RELATED REPORTS
    49. (USD MILLION)
    50. EPINEPHRINE 1:100,000, BY REGION, 2018–2027 (USD MILLION)
    51. DENTAL ANESTHESIA MARKET, FOR LIDOCAINE 2% WITH EPINEPHRINE 1:50,000, BY REGION,
    52. –2027 (USD MILLION)
    53. LIDOCAINE PLAIN, BY REGION, 2018–2027 (USD MILLION)
    54. ANESTHESIA MARKET, FOR MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    55. GLOBAL: DENTAL ANESTHESIA MARKET, FOR MEPIVACAINE 2% WITH LEVONORDEFRIN 1:20,000,
    56. BY REGION, 2018–2027 (USD MILLION)
    57. MARKET, FOR MEPIVACAINE 3%, BY REGION, 2018–2027 (USD MILLION)
    58. GLOBAL: DENTAL ANESTHESIA MARKET, FOR PRILOCAINE, BY TYPE, 2018–2027 (USD
    59. MILLION)
    60. EPINEPHRINE 1:200,000, BY REGION, 2018–2027 (USD MILLION)
    61. DENTAL ANESTHESIA MARKET, FOR PRILOCAINE 4%, BY REGION, 2018–2027 (USD MILLION)
    62. –2027 (USD MILLION)
    63. ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    64. MARKET, FOR ARTICAINE 4% WITH EPINEPHRINE 1:100,00, BY REGION, 2018–2027 (USD
    65. MILLION)
    66. :200,000, BY REGION, 2018–2027 (USD MILLION)
    67. ANESTHESIA MARKET, FOR OTHERS, 2018–2027 (USD MILLION)
    68. DENTAL ANESTHESIA MARKET, BY MODE OF ADMINISTRATION, 2018–2027 (USD MILLION)
    69. (USD MILLION)
    70. INJECTION, BY REGION, 2018–2027 (USD MILLION)
    71. ANESTHESIA MARKET, FOR INTRASEPTAL INJECTION, BY REGION, 2018–2027 (USD MILLION)
    72. BY REGION, 2018–2027 (USD MILLION)
    73. MARKET, FOR PERIAPICAL INJECTION, BY REGION, 2018–2027 (USD MILLION)
    74. GLOBAL: DENTAL ANESTHESIA MARKET, FOR MANDIBULAR, BY TYPE, 2018–2027 (USD
    75. MILLION)
    76. (USD MILLION)
    77. –2027 (USD MILLION)
    78. GOW-GATES, BY REGION, 2018–2027 (USD MILLION)
    79. ANESTHESIA MARKET, FOR TISSUE OR SKIN, BY REGION, 2018–2027 (USD MILLION)
    80. MILLION)
    81. BY REGION, 2018–2027 (USD MILLION)
    82. MARKET, FOR FIELD BLOCK, BY REGION, 2018–2027 (USD MILLION)
    83. GLOBAL: DENTAL ANESTHESIA MARKET, FOR NERVE BLOCK, BY REGION, 2018–2027 (USD
    84. MILLION)
    85. –2027 (USD MILLION)
    86. POSTERIOR SUPERIOR ALVEOLAR, BY REGION, 2018–2027 (USD MILLION)
    87. GLOBAL: DENTAL ANESTHESIA MARKET, FOR MIDDLE SUPERIOR ALVEOLAR, BY REGION, 2018–2027
    88. (USD MILLION)
    89. ALVEOLAR, BY REGION, 2018–2027 (USD MILLION)
    90. ANESTHESIA MARKET, BY DURATION OF ACTION, 2018–2027 (USD MILLION)
    91. GLOBAL: DENTAL ANESTHESIA MARKET, FOR SHORT, BY REGION, 2018–2027 (USD
    92. MILLION)
    93. –2027 (USD MILLION)
    94. LONG, BY REGION, 2018–2027 (USD MILLION)
    95. MARKET, BY END USER, 2018–2027 (USD MILLION)
    96. ANESTHESIA MARKET, FOR HOSPITAL CLINICS, BY REGION, 2018–2027 (USD MILLION)
    97. (USD MILLION)
    98. –2027 (USD MILLION)
    99. DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)
    100. ANESTHESIA MARKET, FOR PHARMACIES AND DRUG STORES, BY REGION, 2018–2027 (USD
    101. MILLION)
    102. –2027 (USD MILLION)
    103. OTHER, BY REGION, 2018–2027 (USD MILLION)
    104. MARKET, BY REGION, 2018–2027 (USD MILLION)
    105. ANESTHESIA MARKET, BY REGION, 2018–2027 (USD MILLION)
    106. DENTAL ANESTHESIA MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    107. AMERICAS: DENTAL ANESTHESIA MARKET FOR LIDOCAINE, BY TYPE, 2018–2027 (USD
    108. MILLION)
    109. –2027 (USD MILLION)
    110. PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    111. ANESTHESIA MARKET ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    112. AMERICAS: DENTAL ANESTHESIA MARKET, BY MODE OF ADMINISTRATION, 2018–2027 (USD
    113. MILLION)
    114. (USD MILLION)
    115. –2027 (USD MILLION)
    116. BY TECHNIQUE, 2018–2027 (USD MILLION)
    117. MARKET NERVE BLOCK, BY TYPE, 2018–2027 (USD MILLION)
    118. DENTAL ANESTHESIA MARKET, BY DURATION OF ACTION, 2018–2027 (USD MILLION)
    119. MILLION)
    120. –2027 (USD MILLION)
    121. BY REGION, 2018–2027 (USD MILLION)
    122. MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    123. DENTAL ANESTHESIA MARKET FOR LIDOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    124. (USD MILLION)
    125. BY TYPE, 2018–2027 (USD MILLION)
    126. MARKET ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    127. DENTAL ANESTHESIA MARKET, BY MODE OF ADMINISTRATION, 2018–2027 (USD MILLION)
    128. (USD MILLION)
    129. BY TYPE, 2018–2027 (USD MILLION)
    130. MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)
    131. DENTAL ANESTHESIA MARKET NERVE BLOCK, BY TYPE, 2018–2027 (USD MILLION)
    132. (USD MILLION)
    133. –2027 (USD MILLION)
    134. BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)
    135. ANESTHESIA MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    136. US: DENTAL ANESTHESIA MARKET FOR LIDOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    137. (USD MILLION)
    138. –2027 (USD MILLION)
    139. BY TYPE, 2018–2027 (USD MILLION)
    140. BY MODE OF ADMINISTRATION, 2018–2027 (USD MILLION)
    141. ANESTHESIA MARKET MAXILLARY, BY TYPE, 2018–2027 (USD MILLION)
    142. US: DENTAL ANESTHESIA MARKET MANDIBULAR, BY TYPE, 2018–2027 (USD MILLION)
    143. MILLION)
    144. (USD MILLION)
    145. (USD MILLION)
    146. –2027 (USD MILLION)
    147. PRODUCT TYPE, 2018–2027 (USD MILLION)
    148. MARKET FOR LIDOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    149. DENTAL ANESTHESIA MARKET FOR MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    150. (USD MILLION)
    151. –2027 (USD MILLION)
    152. MODE OF ADMINISTRATION, 2018–2027 (USD MILLION)
    153. ANESTHESIA MARKET MAXILLARY, BY TYPE, 2018–2027 (USD MILLION)
    154. CANADA: DENTAL ANESTHESIA MARKET MANDIBULAR, BY TYPE, 2018–2027 (USD MILLION)
    155. MILLION)
    156. (USD MILLION)
    157. –2027 (USD MILLION)
    158. END USER, 2018–2027 (USD MILLION)
    159. MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)
    160. AMERICA: DENTAL ANESTHESIA MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    161. (USD MILLION)
    162. BY TYPE, 2018–2027 (USD MILLION)
    163. MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    164. AMERICA: DENTAL ANESTHESIA MARKET ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    165. –2027 (USD MILLION)
    166. MAXILLARY, BY TYPE, 2018–2027 (USD MILLION)
    167. DENTAL ANESTHESIA MARKET MANDIBULAR, BY TYPE, 2018–2027 (USD MILLION)
    168. SOUTH AMERICA: DENTAL ANESTHESIA MARKET, BY TECHNIQUE, 2018–2027 (USD
    169. MILLION)
    170. TYPE, 2018–2027 (USD MILLION)
    171. MARKET, BY DURATION OF ACTION, 2018–2027 (USD MILLION)
    172. AMERICA: DENTAL ANESTHESIA MARKET, BY END USER, 2018–2027 (USD MILLION)
    173. (USD MILLION)
    174. (USD MILLION)
    175. –2027 (USD MILLION)
    176. LIDOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    177. ANESTHESIA MARKET FOR MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    178. EUROPE: DENTAL ANESTHESIA MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD
    179. MILLION)
    180. (USD MILLION)
    181. –2027 (USD MILLION)
    182. BY TYPE, 2018–2027 (USD MILLION)
    183. MARKET MANDIBULAR, BY TYPE, 2018–2027 (USD MILLION)
    184. DENTAL ANESTHESIA MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)
    185. EUROPE: DENTAL ANESTHESIA MARKET NERVE BLOCK, BY TYPE, 2018–2027 (USD
    186. MILLION)
    187. –2027 (USD MILLION)
    188. END USER, 2018–2027 (USD MILLION)
    189. MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)
    190. EUROPE: DENTAL ANESTHESIA MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
    191. WESTERN EUROPE: DENTAL ANESTHESIA MARKET, BY PRODUCT TYPE, 2018–2027 (USD
    192. MILLION)
    193. BY TYPE, 2018–2027 (USD MILLION)
    194. MARKET FOR MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    195. EUROPE: DENTAL ANESTHESIA MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    196. (USD MILLION)
    197. ADMINISTRATION, 2018–2027 (USD MILLION)
    198. ANESTHESIA MARKET MAXILLARY, BY TYPE, 2018–2027 (USD MILLION)
    199. WESTERN EUROPE: DENTAL ANESTHESIA MARKET MANDIBULAR, BY TYPE, 2018–2027 (USD
    200. MILLION)
    201. –2027 (USD MILLION)
    202. NERVE BLOCK, BY TYPE, 2018–2027 (USD MILLION)
    203. DENTAL ANESTHESIA MARKET, BY DURATION OF ACTION, 2018–2027 (USD MILLION)
    204. (USD MILLION)
    205. CHANNEL, 2018–2027 (USD MILLION)
    206. MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    207. ANESTHESIA MARKET FOR LIDOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    208. GERMANY: DENTAL ANESTHESIA MARKET FOR MEPIVACAINE, BY TYPE, 2018–2027
    209. (USD MILLION)
    210. TYPE, 2018–2027 (USD MILLION)
    211. ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    212. ANESTHESIA MARKET, BY MODE OF ADMINISTRATION, 2018–2027 (USD MILLION)
    213. GERMANY: DENTAL ANESTHESIA MARKET MAXILLARY, BY TYPE, 2018–2027 (USD MILLION)
    214. (USD MILLION)
    215. (USD MILLION)
    216. –2027 (USD MILLION)
    217. BY DURATION OF ACTION, 2018–2027 (USD MILLION)
    218. ANESTHESIA MARKET, BY END USER, 2018–2027 (USD MILLION)
    219. DENTAL ANESTHESIA MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)
    220. MILLION)
    221. –2027 (USD MILLION)
    222. MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    223. ANESTHESIA MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    224. FRANCE: DENTAL ANESTHESIA MARKET ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    225. (USD MILLION)
    226. –2027 (USD MILLION)
    227. BY TYPE, 2018–2027 (USD MILLION)
    228. MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)
    229. ANESTHESIA MARKET NERVE BLOCK, BY TYPE, 2018–2027 (USD MILLION)
    230. FRANCE: DENTAL ANESTHESIA MARKET, BY DURATION OF ACTION, 2018–2027 (USD
    231. MILLION)
    232. (USD MILLION)
    233. –2027 (USD MILLION)
    234. TYPE, 2018–2027 (USD MILLION)
    235. FOR LIDOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    236. ANESTHESIA MARKET FOR MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    237. UK: DENTAL ANESTHESIA MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    238. MILLION)
    239. –2027 (USD MILLION)
    240. BY TYPE, 2018–2027 (USD MILLION)
    241. MANDIBULAR, BY TYPE, 2018–2027 (USD MILLION)
    242. MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)
    243. MARKET NERVE BLOCK, BY TYPE, 2018–2027 (USD MILLION)
    244. ANESTHESIA MARKET, BY DURATION OF ACTION, 2018–2027 (USD MILLION)
    245. UK: DENTAL ANESTHESIA MARKET, BY END USER, 2018–2027 (USD MILLION)
    246. (USD MILLION)
    247. (USD MILLION)
    248. –2027 (USD MILLION)
    249. MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    250. ANESTHESIA MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    251. ITALY: DENTAL ANESTHESIA MARKET ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    252. (USD MILLION)
    253. –2027 (USD MILLION)
    254. BY TYPE, 2018–2027 (USD MILLION)
    255. BY TECHNIQUE, 2018–2027 (USD MILLION)
    256. MARKET NERVE BLOCK, BY TYPE, 2018–2027 (USD MILLION)
    257. DENTAL ANESTHESIA MARKET, BY DURATION OF ACTION, 2018–2027 (USD MILLION)
    258. (USD MILLION)
    259. (USD MILLION)
    260. –2027 (USD MILLION)
    261. MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    262. ANESTHESIA MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    263. SPAIN: DENTAL ANESTHESIA MARKET ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    264. (USD MILLION)
    265. –2027 (USD MILLION)
    266. BY TYPE, 2018–2027 (USD MILLION)
    267. BY TECHNIQUE, 2018–2027 (USD MILLION)
    268. MARKET NERVE BLOCK, BY TYPE, 2018–2027 (USD MILLION)
    269. DENTAL ANESTHESIA MARKET, BY DURATION OF ACTION, 2018–2027 (USD MILLION)
    270. (USD MILLION)
    271. PRODUCT TYPE, 2018–2027 (USD MILLION)
    272. DENTAL ANESTHESIA MARKET FOR LIDOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    273. TYPE, 2018–2027 (USD MILLION)
    274. ANESTHESIA MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    275. REST OF WESTERN EUROPE: DENTAL ANESTHESIA MARKET ARTICAINE, BY TYPE, 2018–2027
    276. (USD MILLION)
    277. MODE OF ADMINISTRATION, 2018–2027 (USD MILLION)
    278. EUROPE: DENTAL ANESTHESIA MARKET MAXILLARY, BY TYPE, 2018–2027 (USD MILLION)
    279. –2027 (USD MILLION)
    280. MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)
    281. EUROPE: DENTAL ANESTHESIA MARKET NERVE BLOCK, BY TYPE, 2018–2027 (USD MILLION)
    282. –2027 (USD MILLION)
    283. MARKET, BY END USER, 2018–2027 (USD MILLION)
    284. EUROPE: DENTAL ANESTHESIA MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD
    285. MILLION)
    286. –2027 (USD MILLION)
    287. FOR LIDOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    288. DENTAL ANESTHESIA MARKET FOR MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    289. (USD MILLION)
    290. BY TYPE, 2018–2027 (USD MILLION)
    291. MARKET, BY MODE OF ADMINISTRATION, 2018–2027 (USD MILLION)
    292. EASTERN EUROPE: DENTAL ANESTHESIA MARKET MAXILLARY, BY TYPE, 2018–2027 (USD
    293. MILLION)
    294. TYPE, 2018–2027 (USD MILLION)
    295. MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)
    296. DENTAL ANESTHESIA MARKET NERVE BLOCK, BY TYPE, 2018–2027 (USD MILLION)
    297. (USD MILLION)
    298. –2027 (USD MILLION)
    299. BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)
    300. DENTAL ANESTHESIA MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
    301. ASIA-PACIFIC: DENTAL ANESTHESIA MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    302. (USD MILLION)
    303. BY TYPE, 2018–2027 (USD MILLION)
    304. MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    305. DENTAL ANESTHESIA MARKET ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    306. ASIA-PACIFIC: DENTAL ANESTHESIA MARKET, BY MODE OF ADMINISTRATION, 2018–2027
    307. (USD MILLION)
    308. TYPE, 2018–2027 (USD MILLION)
    309. MARKET MANDIBULAR, BY TYPE, 2018–2027 (USD MILLION)
    310. DENTAL ANESTHESIA MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)
    311. ASIA-PACIFIC: DENTAL ANESTHESIA MARKET NERVE BLOCK, BY TYPE, 2018–2027
    312. (USD MILLION)
    313. OF ACTION, 2018–2027 (USD MILLION)
    314. MARKET, BY END USER, 2018–2027 (USD MILLION)
    315. DENTAL ANESTHESIA MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)
    316. MILLION)
    317. –2027 (USD MILLION)
    318. MEPIVACAINE, BY TYPE, 2018–2027 (USD MILLION)
    319. ANESTHESIA MARKET FOR PRILOCAINE, BY TYPE, 2018–2027 (USD MILLION)
    320. CHINA: DENTAL ANESTHESIA MARKET ARTICAINE, BY TYPE, 2018–2027 (USD MILLION)
    321. (USD MILLION)
    322. –2027 (USD MILLION)
    323. BY T'

    Dental Anesthesia Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Dental Anesthesia Market Research Report—Global Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials